文献速递乳房整形与再造

胸肌前乳房再造在乳房切除术后放疗中的应用:临床结局与获益评估

Prepectoral Breast Reconstruction in the Setting of Postmastectomy Radiation Therapy: An Assessment of Clinical Outcomes and Benefits.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

该研究回顾性分析单术者2015至2017年立即胸肌前乳房再造后接受乳房切除术后放疗的病例,并与同期胸肌下/双平面再造后放疗者比较。结果显示两组放疗比例相似,并发症发生率无显著差异,包括取出假体率(15.4% vs 19.3%,p=0.695)。结论认为胸肌前再造在放疗背景下安全有效,发病率与胸肌下再造相似。

要点

  • 胸肌前乳房再造后接受放疗的并发症发生率与胸肌下再造相似。
  • 两组假体取出率分别为15.4%和19.3%,无统计学差异。
  • 胸肌前再造在放疗背景下是安全有效的选择。

核心结论

  • 胸肌前乳房再造在乳房切除术后放疗背景下是安全有效的选择,发病率与胸肌下再造相似。

研究设计与样本

  • 单术者回顾性研究,纳入2015至2017年立即胸肌前乳房再造后放疗的乳房,并与同期胸肌下/双平面再造后放疗者比较。

主要发现

  • 胸肌前组175个乳房,胸肌下/双平面组236个乳房。
  • 接受辅助放疗的比例胸肌前组为26个乳房(14.9%),胸肌下组为31个乳房(13.1%)(p=0.6180)。
  • 放疗背景下两组并发症发生率无显著差异,包括取出假体率(15.4% vs 19.3%;p=0.695)。

临床怎么用

  • 对于需行乳房切除术后放疗的患者,胸肌前乳房再造可作为安全有效的重建选项。

局限性

  • 证据等级为治疗性III级,为单术者回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prepectoral breast reconstruction following mastectomy has become a more widely performed technique in recent years because of its numerous benefits for women. These include full pectoralis muscle preservation, reduced loss of strength, reduced pain, and elimination of animation deformity. As with any breast reconstruction technique, widespread adoption is dependent on a low morbidity profile in the setting of postmastectomy radiation therapy, as this adjuvant therapy is routine in breast cancer treatment. The authors assess the clinical outcomes of patients undergoing postmastectomy radiation therapy following prepectoral breast reconstruction, and compare these to outcomes of patients undergoing postmastectomy radiation therapy with submuscular reconstruction. METHODS: A single surgeon's experience with immediate prepectoral breast reconstruction, followed by postmastectomy radiation therapy, from 2015 to 2017 was reviewed. Patient demographics and incidence of complications during the tissue expander stage were assessed. In addition, the morbidity profile of these patients was compared to that of patients undergoing submuscular/dual-plane reconstruction and postmastectomy radiation therapy over the same period. RESULTS: Over 3 years, 175 breasts underwent immediate prepectoral reconstruction, and 236 breasts underwent immediate submuscular/dual-plane reconstruction. Overall rates of adjuvant radiation therapy (postmastectomy radiation therapy) were similar between prepectoral [26 breasts (14.9 percent)] and submuscular [31 breasts (13.1 percent)] (p = 0.6180) reconstruction. There were no significant differences in complication rates between the two reconstructive cohorts, in the setting of postmastectomy radiation therapy, including rates of explantation (15.4 percent versus 19.3 percent; p = 0.695). CONCLUSIONS: Prepectoral breast reconstruction is a safe and effective option in the setting of postmastectomy radiation therapy. The morbidity profile is similar to that encountered with submuscular reconstruction in this setting. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sbitany H, Gomez-Sanchez C, Piper M, et al. Prepectoral Breast Reconstruction in the Setting of Postmastectomy Radiation Therapy: An Assessment of Clinical Outcomes and Benefits. Plast Reconstr Surg. 2019. PMID: 30589770. doi:10.1097/PRS.0000000000005140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。